[Journal logo]

Volume 66 
Part 6 
Pages m684-m685  
June 2010  

Received 25 April 2010
Accepted 14 May 2010
Online 22 May 2010

Key indicators
Single-crystal X-ray study
T = 193 K
Mean [sigma](C-C) = 0.007 Å
R = 0.073
wR = 0.167
Data-to-parameter ratio = 12.5
Details
Open access

Bis[4-amino-N-(pyrimidin-2-yl)benzenesulfonamidato](2,2'-bipyridine)manganese(II)

aKey Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry & Chemical Engineering, Guangxi Normal University, Guilin 541004, People's Republic of China
Correspondence e-mail: chenzfgxnu@yahoo.com

The title compound, [Mn(C10H9N4O2S)2(C10H8N2)], contains a distorted octahedral [Mn(sdz)2(bpy)] (sdz is the sulfadiazine anion and bpy is 2,2'-bipyridine) complex molecule. A three-dimensional network is generated by N-H...N, N-H...O and C-H...O hydrogen bonds from the sulfadiazine ligands.

Related literature

For mono-ligand sulfadiazine-metal complexes, see: Yuan et al. (2001[Yuan, R.-X., Xiong, R.-G., Chen, Z.-F., Zhang, P., Ju, H.-X., Dai, Z., Guo, Z.-J., Fun, H.-K. & You, X.-Z. (2001). J. Chem. Soc. Dalton Trans. pp. 774-776.]); Wang et al. (2005[Wang, X.-S., Huang, X.-F. & Xiong, R.-G. (2005). Chin. J. Inorg. Chem. 21, 1279-1280.]). For mixed-ligand sulfadiazine-metal complexes, see: Ajibade et al. (2006[Ajibade, P. A., Kolawole, G. A., O'Brien, P., Helliwell, M. & Raftery, J. (2006). Inorg. Chim. Acta, 359, 3111-3116.]); Brown et al. (1987[Brown, C. J., Cook, D. S. & Sengier, L. (1987). Acta Cryst. C43, 2332-2334.]); Hossain et al. (2006[Hossain, G. M. G., Banu, A. & Amoroso, A. J. (2006). Acta Cryst. E62, m2727-m2729.]); Wang et al. (2009[Wang, Y.-F., Li, F.-X., Peng, Y., Chen, Z.-F. & Liang, H. (2009). Acta Cryst. E65, m1584.], 2010[Wang, Y.-F., Zou, H.-L., Luo, X.-J., Chen, Z.-F. & Liang, H. (2010). Acta Cryst. E66, m548.]). For 2,2'-bipyridine-Mn(II) complexes, see: Chen et al. (1995[Chen, X.-M., Wang, R.-Q. & Xu, Z.-T. (1995). Acta Cryst. C51, 820-822.]); Cheng et al. (2004[Cheng, Y.-Q., Hu, M.-L., Fan, S.-R. & Zhang, W. (2004). Acta Cryst. E60, m212-m213.]).

[Scheme 1]

Experimental

Crystal data
  • [Mn(C10H9N4O2S)2(C10H8N2)]

  • Mr = 709.67

  • Monoclinic, C 2/c

  • a = 20.121 (3) Å

  • b = 17.555 (3) Å

  • c = 17.956 (3) Å

  • [beta] = 106.973 (4)°

  • V = 6066.4 (17) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 0.63 mm-1

  • T = 193 K

  • 0.25 × 0.17 × 0.15 mm

Data collection
  • Rigaku Mercury CCD diffractometer

  • Absorption correction: multi-scan (REQAB; Jacobson, 1998[Jacobson, R. (1998). REQAB. Private communication to the Rigaku Corporation, Tokyo, Japan.]) Tmin = 0.859, Tmax = 0.912

  • 28490 measured reflections

  • 5533 independent reflections

  • 4438 reflections with I > 2[sigma](I)

  • Rint = 0.077

Refinement
  • R[F2 > 2[sigma](F2)] = 0.073

  • wR(F2) = 0.167

  • S = 1.17

  • 5533 reflections

  • 441 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.43 e Å-3

  • [Delta][rho]min = -0.58 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N8-H8B...O2i 0.87 (6) 2.17 (6) 3.011 (6) 163 (5)
N4-H4A...N3ii 0.82 (5) 2.23 (5) 3.003 (6) 156 (5)
C12-H12...O1iii 0.95 2.32 3.248 (6) 165
Symmetry codes: (i) [x, -y+1, z-{\script{1\over 2}}]; (ii) -x+2, -y+1, -z+1; (iii) [-x+{\script{3\over 2}}, -y+{\script{3\over 2}}, -z+1].

Data collection: CrystalClear (Rigaku, 1999[Rigaku (1999). CrystalClear. Rigaku Corporation, Tokyo, Japan.]); cell refinement: CrystalClear; data reduction: CrystalStructure (Rigaku/MSC & Rigaku, 2000[Rigaku/MSC & Rigaku (2000). CrystalStrucutre. Rigaku/MSC, The Woodands, Texas, USA, and Rigaku Coporation, Tokyo, Japan.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HG2677 ).


Acknowledgements

The authors thank the Guangxi Natural Science Foundation of China (No. 0991003, 2010GXNSFF013001) and the Open Foundation of the Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China) for financial support.

References

Ajibade, P. A., Kolawole, G. A., O'Brien, P., Helliwell, M. & Raftery, J. (2006). Inorg. Chim. Acta, 359, 3111-3116.  [ISI] [CSD] [CrossRef] [ChemPort]
Brown, C. J., Cook, D. S. & Sengier, L. (1987). Acta Cryst. C43, 2332-2334.  [CrossRef] [details]
Chen, X.-M., Wang, R.-Q. & Xu, Z.-T. (1995). Acta Cryst. C51, 820-822.  [CrossRef] [details]
Cheng, Y.-Q., Hu, M.-L., Fan, S.-R. & Zhang, W. (2004). Acta Cryst. E60, m212-m213.  [CSD] [CrossRef] [details]
Hossain, G. M. G., Banu, A. & Amoroso, A. J. (2006). Acta Cryst. E62, m2727-m2729.  [CSD] [CrossRef] [details]
Jacobson, R. (1998). REQAB. Private communication to the Rigaku Corporation, Tokyo, Japan.
Rigaku (1999). CrystalClear. Rigaku Corporation, Tokyo, Japan.
Rigaku/MSC & Rigaku (2000). CrystalStrucutre. Rigaku/MSC, The Woodands, Texas, USA, and Rigaku Coporation, Tokyo, Japan.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Wang, X.-S., Huang, X.-F. & Xiong, R.-G. (2005). Chin. J. Inorg. Chem. 21, 1279-1280.  [ChemPort]
Wang, Y.-F., Li, F.-X., Peng, Y., Chen, Z.-F. & Liang, H. (2009). Acta Cryst. E65, m1584.  [CSD] [CrossRef] [details]
Wang, Y.-F., Zou, H.-L., Luo, X.-J., Chen, Z.-F. & Liang, H. (2010). Acta Cryst. E66, m548.  [CrossRef] [details]
Yuan, R.-X., Xiong, R.-G., Chen, Z.-F., Zhang, P., Ju, H.-X., Dai, Z., Guo, Z.-J., Fun, H.-K. & You, X.-Z. (2001). J. Chem. Soc. Dalton Trans. pp. 774-776.  [CSD] [CrossRef]


Acta Cryst (2010). E66, m684-m685   [ doi:10.1107/S1600536810017794 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.